CRISM Therapeutics Corporation (AIM:CRTX)
London · Delayed Price · Currency is GBP · Price in GBX 10.50
-0.75 (-6.67%)
Sep 4, 2026, 4:34 PM GMT
CRISM Therapeutics Market Cap
CRISM Therapeutics has a market cap or net worth of 6.1 million as of September 4, 2026. Its market cap has increased by 45.41% in one year.
Market Cap
6.10M
Enterprise Value
4.97M
Revenue
231.00K
Ranking
n/a
PE Ratio
n/a
Stock Price
10.50
ChartMarket Cap Chart
Since March 15, 2006, CRISM Therapeutics's market cap has decreased from 28.23M to 6.10M, a decrease of -78.39%. That is a compound annual growth rate of -7.21%.
| Date | Market Cap | % Change |
|---|---|---|
| Sep 3, 2026 | 6.10M | 17.94% |
| Dec 31, 2025 | 5.17M | 43.93% |
| Dec 31, 2024 | 3.59M | -74.19% |
| Dec 30, 2022 | 13.93M | -40.80% |
| Dec 31, 2021 | 23.53M | 6.56% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2016 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Related Stocks
| Company | Market Cap |
|---|---|
| Fusion Antibodies | 14.71M |
| Genflow Biosciences | 12.18M |
| Aptamer Group | 12.09M |
| Solvonis Therapeutics | 8.17M |
| Cizzle Biotechnology Holdings | 6.37M |
| OptiBiotix Health | 5.94M |
| Thalia Therapeutics | 5.20M |
| Oxford BioDynamics | 4.93M |